SAP30BP

SAP30-binding protein · Q9UHR5 · SAP30BP on Sugi Atlas →

0 patent compounds predicted against SAP30BP, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SAP30BP by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Symbicort ® on GR in Sputum in COPD PHASE4COMPLETED
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room PHASE2/PHASE3COMPLETED
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination PHASE1/PHASE2COMPLETED
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
NEO100 and High-Grade Meningioma PHASE2RECRUITING
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
A Study of APX3330 in Patients With Advanced Solid Tumors PHASE1COMPLETED
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP) PHASE1UNKNOWN
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Short-Term Application of Tocilizumab Following Myocardial Infarction nanCOMPLETED
Hydroxychloroquin (HCQ) in chILD of Genetic Defect nanCOMPLETED
Evaluation of a Novel PET Radioligand to Image OGA nanCOMPLETED
Biological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHs nanUNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices nanACTIVE_NOT_RECRUITING
Blood-based Biomarkers for the Prognosis of Sports Related Concussion nanCOMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Exercise on Expression of Heat Shock Protein 70 in Arterial Risk nanCOMPLETED
Biomarkers in Idiopathic Juvenile Arthritis nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SAP30BP binder may also engage these)

ProteinNameSimilarity
Q02614 1.000 Q02614 →
Q58A65 0.980 Q58A65 →
SF3A1 Splicing factor 3A subunit 1 0.979 landscape →
A2AQ19 0.979 A2AQ19 →
RTF1 RNA polymerase-associated protein RTF1 homolog 0.978 landscape →
D3ZTQ1 0.978 D3ZTQ1 →
Q5RAD5 0.978 Q5RAD5 →
Q6DC60 0.977 Q6DC60 →
Q5ZJ85 0.976 Q5ZJ85 →
Q91WE2 0.976 Q91WE2 →
A2VDN6 0.976 A2VDN6 →
Q91WD1 0.976 Q91WD1 →
Q3UJB0 0.976 Q3UJB0 →
Q8K4Z5 0.976 Q8K4Z5 →
PRPF3 U4/U6 small nuclear ribonucleoprotein Prp3 0.975 landscape →
Q3USH5 0.975 Q3USH5 →
Q9GZU8 0.975 Q9GZU8 →
Q9WU42 0.975 Q9WU42 →
Q9P2N5 0.974 Q9P2N5 →
P49140 0.974 P49140 →
Q922U1 0.974 Q922U1 →
P29536 0.974 P29536 →
Q8BVA4 0.974 Q8BVA4 →
Q80UV9 0.974 Q80UV9 →
Q5R5F1 0.974 Q5R5F1 →
Q60544 0.973 Q60544 →
Q9H8E8 0.973 Q9H8E8 →
Q12872 0.973 Q12872 →
Q9D5V6 0.973 Q9D5V6 →
Q8N2M8 0.973 Q8N2M8 →